Prior to joining MCRA in 2019 from Johnson & Johnson, Ms. Dowd held the title of Global Franchise Director of Healthcare Economics and Market Access within Johnson & Johnson's medical device division. Throughout her tenure at Johnson & Johnson, Ms. Dowd demonstrated her leadership and drive for success across several medical device companies, including Biosense Webster, Ethicon Endo-Surgery, and Acclarent, where her leadership and innovative reimbursement solutions contributed to successful third-party payer partnerships, and adoption of new technologies in electrophysiology, urology, gastroenterology, otolaryngology, and general surgery. Ms. Dowd played a significant role in the broad market adoption of bariatric surgery, pioneering reimbursement pathways and patient access through collaborations with Johnson & Johnson government affairs, specialty societies, health technology assessment, and third-party payer organizations.
Ms. Dowd holds an undergraduate degree from the University of Michigan in Health Policy, as well as an MPH and Global Healthcare from the University of California, Los Angeles.
In addition to, and prior to rejoining Johnson & Johnson in 2017, Ms. Dowd founded TD and Associates, LLC, a consulting company serving the life sciences, Vice President of Reimbursement for EnteroMedics, and head of the Reimbursement Policy and Market Access business unit at Quorum Consulting. In these various leadership roles, she was responsible for business development, strategic product planning, client and associate management, upstream strategic product plan development and downstream execution of reimbursement strategies across a varied portfolio of clients in the molecular diagnostic and medical device arenas.
Overview
Ms. Dowd is strategic, practical, and opportunistic in her approach to Reimbursement and Market Access, all of which she brings with her in her new role at MCRA, LLC. With an expertise and knowledge of global macro healthcare policy trends, and direct experience in tactical execution of successful Market Access and Reimbursement strategies, her understanding of how policy is translated into practice sets her apart as a unique and innovative leader in the Reimbursement field.